27-Hydroxycholesterol Induces Aberrant Morphology and Synaptic Dysfunction in Hippocampal Neurons

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Hypercholesterolemia is a known risk factor for neurodegenerative diseases.
• The precise molecular mechanisms linking high cholesterol to neurodegeneration remain unclear.
• Cholesterol metabolites, such as 27-hydroxycholesterol (27-OH), can cross the blood-brain barrier.

Purpose of the Study:

• To investigate the impact of excess 27-hydroxycholesterol (27-OH) on neuronal structure and function.
• To elucidate the molecular pathways through which 27-OH may contribute to neurodegeneration.
• To explore potential therapeutic strategies targeting 27-OH for neuroprotection.

Main Methods:

• Assessment of neuronal morphology and dendritic spine density in response to 27-OH.
• Quantification of postsynaptic density protein 95 (PSD95) levels.
• Analysis of the REST-miR124a-PTBP1 axis regulation by 27-OH, potentially involving RxRγ.

Main Results:

• Excess 27-OH impairs neuronal morphology and reduces hippocampal spine density.
• Levels of the crucial synaptic protein PSD95 are decreased by 27-OH.
• High 27-OH induces dysregulation of the REST-miR124a-PTBP1 axis, suggesting a mechanism for PSD95 reduction.

Conclusions:

• 27-hydroxycholesterol (27-OH) negatively impacts neuronal structure and synaptic protein levels.
• Dysregulation of the REST-miR124a-PTBP1 axis by 27-OH offers a molecular link between hypercholesterolemia and neurodegeneration.
• Reducing 27-OH levels may represent a viable strategy to prevent cognitive and memory deficits in neurodegenerative disorders.